| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Douglas Love | CEO;Pres | 2026-09-24 | 26,065 | $3.83 | $99.83kBuy |
| Ted Yednock | EVP CHIEF INNOVATION OFFICER | 2026-06-11 | 30,646 | $1.85 | $56.70kBuy |
| Muneer A. Satter | Director | 2026-05-28 | 613,497 | $5.41 | $3.32MBuy |
| William H. Carson | Director | 2026-05-11 | 8,000 | $5.78 | $46.24kBuy |
| William H. Carson | Director | 2026-04-10 | 8,000 | $6.20 | $49.60kBuy |
| William H. Carson | Director | 2026-03-10 | 8,000 | $5.67 | $45.36kBuy |
| Jennifer Lew | EVP CHIEF FINANCIAL OFFICER | 2026-03-02 | 5,565 | $5.42 | $30.16kSell |
| Dean Richard Artis | EVP CHIEF SCIENTIFIC OFFICER | 2026-03-02 | 5,894 | $5.43 | $32.00kSell |
| Jamie Dananberg | CHIEF MEDICAL OFFICER | 2026-03-02 | 5,820 | $5.43 | $31.60kSell |
| Michael Overdorf | EVP CHIEF BUSINESS OFFICER | 2026-03-02 | 4,339 | $5.42 | $23.52kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors LLC | 5.86% | 11,103,852 | $40.42M | Insider |
| Muneer A. Satter | 5.46% | 10,342,134 | $37.65M | Insider |
| Clarus Lifesciences III LP | 1.44% | 2,730,635 | $9.94M | Insider |
| James E. Flynn | 0.85% | 1,617,828 | $5.89M | Insider |
| Redmile Group LLC | 0.84% | 1,596,222 | $5.81M | Insider |
| Douglas Love | 0.21% | 390,476 | $1.42M | Insider |
| Ted Yednock | 0.10% | 184,807 | $672.70k | Insider |
| Michael Overdorf | 0.10% | 182,625 | $664.76k | Insider |
| Dean Richard Artis | 0.09% | 180,093 | $655.54k | Insider |
| Jennifer Lew | 0.09% | 170,700 | $621.35k | Insider |